The PMHNP is treating a 46-year-old woman who has been taking paroxetine (Paxil) for 10 years. She has been trying to discontinue the medication for several weeks but is struggling with withdrawal symptoms. The PMHNP understands this is due to which of the following reasons?

Choice A reason: Paroxetine has a relatively short half-life of approximately 21 hours, which contributes to rapid fluctuations in plasma levels when the drug is discontinued. This abrupt drop in serotonin levels can lead to significant withdrawal symptoms such as dizziness, nausea, irritability, and "brain zaps." The short half-life makes it one of the SSRIs most associated with severe discontinuation syndrome. Choice B reason: A long half-life, such as that of fluoxetine, tends to result in a more gradual decline in drug levels, reducing the severity of withdrawal symptoms. Paroxetine’s short half-life makes this choice incorrect. Choice C reason: While concomitant medications can influence withdrawal experiences, the primary reason for paroxetine’s withdrawal symptoms is its pharmacokinetic profile, not drug interactions. Choice D reason: Although paroxetine is metabolized via the CYP450 system, this pathway does not directly explain the intensity of withdrawal symptoms. The metabolism route is more relevant to drug interactions than to withdrawal severity.